paclitaxel has been researched along with Adrenocortical Carcinoma in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
da Conceição, BB; da Silva, JCL; de Paula Mariani, BM; Dos Santos Passaia, B; Fragoso, MCBV; Kremer, JL; Lima, K; Lotfi, CFP; Machado-Neto, JA; Zerbini, MCN | 1 |
Beuschlein, F; Hantel, C; Jung, S; Mussack, T; Reincke, M | 1 |
Bertherat, J; Beuschlein, F; Frantsev, R; Hantel, C; Jäckel, C; Lira, R; Mussack, T; Ozimek, A; Ragazzon, B; Reincke, M | 1 |
Ardito, A; Baudin, E; Berruti, A; Daffara, F; De Francia, S; Ferrero, A; Generali, D; Germano, A; Leboulleux, S; Papotti, M; Perotti, P; Priola, AM; Sperone, P; Terzolo, M; Volante, M | 1 |
1 trial(s) available for paclitaxel and Adrenocortical Carcinoma
Article | Year |
---|---|
Phase II study of weekly paclitaxel and sorafenib as second/third-line therapy in patients with adrenocortical carcinoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Cell Line, Tumor; Disease-Free Survival; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Niacinamide; Paclitaxel; Phenylurea Compounds; Prospective Studies; Pyridines; Sorafenib | 2012 |
3 other study(ies) available for paclitaxel and Adrenocortical Carcinoma
Article | Year |
---|---|
Stathmin 1 is highly expressed and associated with survival outcome in malignant adrenocortical tumours.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Biomarkers, Tumor; Cell Line, Tumor; Cell Movement; Child, Preschool; Disease-Free Survival; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Paclitaxel; Prognosis; RNA, Messenger; Stathmin | 2020 |
Liposomal polychemotherapy improves adrenocortical carcinoma treatment in a preclinical rodent model.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Albumins; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Cell Proliferation; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Immunoenzyme Techniques; Mice; Mice, Nude; Mitotane; Paclitaxel; Polyethylene Glycols; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2014 |
TNF alpha signaling is associated with therapeutic responsiveness to vascular disrupting agents in endocrine tumors.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Angiogenesis Inhibitors; Animals; Cell Line, Tumor; DNA-Binding Proteins; Female; Humans; Interleukin-1 Receptor-Associated Kinases; Intracellular Signaling Peptides and Proteins; Kaplan-Meier Estimate; Mice, Nude; Nuclear Proteins; Paclitaxel; Proportional Hazards Models; Signal Transduction; Transcriptional Activation; Tumor Necrosis Factor alpha-Induced Protein 3; Tumor Necrosis Factor-alpha; Xanthones; Xenograft Model Antitumor Assays | 2016 |